Oncology Section EDGE Task Force on Cancer

A Systematic Review of Patient-Reported Measures for Sexual Dysfunction

Meryl Alappattu, Shana E. Harrington, Alexandra Hill, Amanda Roscow, Alicia Jeffrey

Research output: Contribution to journalReview article

Abstract

Background: Sexual dysfunction is an important and infrequently addressed issue in patients with cancer. Purpose: To identify self-report measures for assessing sexual dysfunction and to evaluate their psychometric properties and relevance to patients with cancer. Methods: Multiple electronic databases (CINAHL, MEDLINE, PsycINFO) were reviewed using specific search terms to locate articles that identify self-report measures assessing sexual dysfunction. From the 1118 articles reviewed, 21 measures were selected for analysis. Each measure was independently reviewed and rated by 2 reviewers using the Cancer EDGE Task Force Outcome Measure Rating Form. Any discrepancies between reviewers were discussed, and an overall recommendation for each measure was made using the 4-point Cancer EDGE Task Force Rating Scale. Results: On the basis of the psychometric properties and relevance to patients with cancers, we highly recommend the following 4 measures: Sexual Function-Vaginal Changes Questionnaire; International Index of Erectile Function; Erection Hardness Score; and Sexual Health Inventory for Men (aka International Index of Erectile Function-5). We recommend one measure, the Sexual Interest and Desire Inventory. We are unable to recommend 8 measures, based on limited psychometric information and/or clinical utility. Finally, we do not recommend an additional 8 measures. Conclusions: Five of the 21 sexual dysfunction measures demonstrated satisfactory psychometric properties and application to the cancer population and are thereby recommended for clinical use in patients with cancer.

Original languageEnglish (US)
Pages (from-to)137-143
Number of pages7
JournalRehabilitation Oncology
Volume35
Issue number3
DOIs
StatePublished - Jul 1 2017
Externally publishedYes

Fingerprint

Advisory Committees
Psychometrics
Neoplasms
Self Report
Equipment and Supplies
Reproductive Health
Hardness
MEDLINE
Outcome Assessment (Health Care)
Databases
Population

All Science Journal Classification (ASJC) codes

  • Physical Therapy, Sports Therapy and Rehabilitation
  • Rehabilitation
  • Oncology
  • Oncology(nursing)

Cite this

Oncology Section EDGE Task Force on Cancer : A Systematic Review of Patient-Reported Measures for Sexual Dysfunction. / Alappattu, Meryl; Harrington, Shana E.; Hill, Alexandra; Roscow, Amanda; Jeffrey, Alicia.

In: Rehabilitation Oncology, Vol. 35, No. 3, 01.07.2017, p. 137-143.

Research output: Contribution to journalReview article

Alappattu, Meryl ; Harrington, Shana E. ; Hill, Alexandra ; Roscow, Amanda ; Jeffrey, Alicia. / Oncology Section EDGE Task Force on Cancer : A Systematic Review of Patient-Reported Measures for Sexual Dysfunction. In: Rehabilitation Oncology. 2017 ; Vol. 35, No. 3. pp. 137-143.
@article{8ea2f6e8d2224ccd9a3779c6d23c1e88,
title = "Oncology Section EDGE Task Force on Cancer: A Systematic Review of Patient-Reported Measures for Sexual Dysfunction",
abstract = "Background: Sexual dysfunction is an important and infrequently addressed issue in patients with cancer. Purpose: To identify self-report measures for assessing sexual dysfunction and to evaluate their psychometric properties and relevance to patients with cancer. Methods: Multiple electronic databases (CINAHL, MEDLINE, PsycINFO) were reviewed using specific search terms to locate articles that identify self-report measures assessing sexual dysfunction. From the 1118 articles reviewed, 21 measures were selected for analysis. Each measure was independently reviewed and rated by 2 reviewers using the Cancer EDGE Task Force Outcome Measure Rating Form. Any discrepancies between reviewers were discussed, and an overall recommendation for each measure was made using the 4-point Cancer EDGE Task Force Rating Scale. Results: On the basis of the psychometric properties and relevance to patients with cancers, we highly recommend the following 4 measures: Sexual Function-Vaginal Changes Questionnaire; International Index of Erectile Function; Erection Hardness Score; and Sexual Health Inventory for Men (aka International Index of Erectile Function-5). We recommend one measure, the Sexual Interest and Desire Inventory. We are unable to recommend 8 measures, based on limited psychometric information and/or clinical utility. Finally, we do not recommend an additional 8 measures. Conclusions: Five of the 21 sexual dysfunction measures demonstrated satisfactory psychometric properties and application to the cancer population and are thereby recommended for clinical use in patients with cancer.",
author = "Meryl Alappattu and Harrington, {Shana E.} and Alexandra Hill and Amanda Roscow and Alicia Jeffrey",
year = "2017",
month = "7",
day = "1",
doi = "10.1097/01.REO.0000000000000071",
language = "English (US)",
volume = "35",
pages = "137--143",
journal = "Rehabilitation Oncology",
issn = "2168-3808",
publisher = "American Physical Therapy Association",
number = "3",

}

TY - JOUR

T1 - Oncology Section EDGE Task Force on Cancer

T2 - A Systematic Review of Patient-Reported Measures for Sexual Dysfunction

AU - Alappattu, Meryl

AU - Harrington, Shana E.

AU - Hill, Alexandra

AU - Roscow, Amanda

AU - Jeffrey, Alicia

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Background: Sexual dysfunction is an important and infrequently addressed issue in patients with cancer. Purpose: To identify self-report measures for assessing sexual dysfunction and to evaluate their psychometric properties and relevance to patients with cancer. Methods: Multiple electronic databases (CINAHL, MEDLINE, PsycINFO) were reviewed using specific search terms to locate articles that identify self-report measures assessing sexual dysfunction. From the 1118 articles reviewed, 21 measures were selected for analysis. Each measure was independently reviewed and rated by 2 reviewers using the Cancer EDGE Task Force Outcome Measure Rating Form. Any discrepancies between reviewers were discussed, and an overall recommendation for each measure was made using the 4-point Cancer EDGE Task Force Rating Scale. Results: On the basis of the psychometric properties and relevance to patients with cancers, we highly recommend the following 4 measures: Sexual Function-Vaginal Changes Questionnaire; International Index of Erectile Function; Erection Hardness Score; and Sexual Health Inventory for Men (aka International Index of Erectile Function-5). We recommend one measure, the Sexual Interest and Desire Inventory. We are unable to recommend 8 measures, based on limited psychometric information and/or clinical utility. Finally, we do not recommend an additional 8 measures. Conclusions: Five of the 21 sexual dysfunction measures demonstrated satisfactory psychometric properties and application to the cancer population and are thereby recommended for clinical use in patients with cancer.

AB - Background: Sexual dysfunction is an important and infrequently addressed issue in patients with cancer. Purpose: To identify self-report measures for assessing sexual dysfunction and to evaluate their psychometric properties and relevance to patients with cancer. Methods: Multiple electronic databases (CINAHL, MEDLINE, PsycINFO) were reviewed using specific search terms to locate articles that identify self-report measures assessing sexual dysfunction. From the 1118 articles reviewed, 21 measures were selected for analysis. Each measure was independently reviewed and rated by 2 reviewers using the Cancer EDGE Task Force Outcome Measure Rating Form. Any discrepancies between reviewers were discussed, and an overall recommendation for each measure was made using the 4-point Cancer EDGE Task Force Rating Scale. Results: On the basis of the psychometric properties and relevance to patients with cancers, we highly recommend the following 4 measures: Sexual Function-Vaginal Changes Questionnaire; International Index of Erectile Function; Erection Hardness Score; and Sexual Health Inventory for Men (aka International Index of Erectile Function-5). We recommend one measure, the Sexual Interest and Desire Inventory. We are unable to recommend 8 measures, based on limited psychometric information and/or clinical utility. Finally, we do not recommend an additional 8 measures. Conclusions: Five of the 21 sexual dysfunction measures demonstrated satisfactory psychometric properties and application to the cancer population and are thereby recommended for clinical use in patients with cancer.

UR - http://www.scopus.com/inward/record.url?scp=85021781168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021781168&partnerID=8YFLogxK

U2 - 10.1097/01.REO.0000000000000071

DO - 10.1097/01.REO.0000000000000071

M3 - Review article

VL - 35

SP - 137

EP - 143

JO - Rehabilitation Oncology

JF - Rehabilitation Oncology

SN - 2168-3808

IS - 3

ER -